We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XEC
1701
DELISTED
CIMAREX ENERGY CO
XEC
| $207K | ﹤0.01% |
2,965
-1,773
| -37% | -$128K |
|
1702
LendingTree
TREE
$578M
| $206K | ﹤0.01% |
+586
| New | +$177K |
|
|
CTRA
1703
DELISTED
Coterra Energy
CTRA
| $205K | ﹤0.01% |
7,849
-3,314
| -30% | -$83.1K |
|
|
ALEX
1704
DELISTED
Alexander & Baldwin
ALEX
| $203K | ﹤0.01% |
+7,990
| New | +$183K |
|
|
ELME
1705
Elme Communities
ELME
$132M
| $203K | ﹤0.01% |
+7,158
| New | +$186K |
|
1706
Supernus Pharmaceuticals
SUPN
$2.72B
| $203K | ﹤0.01% |
+5,796
| New | +$216K |
|
1707
Forrester Research
FORR
$175M
| $200K | ﹤0.01% |
+4,146
| New | +$193K |
|
1708
First Commonwealth Financial
FCF
$2.12B
| $199K | ﹤0.01% |
15,790
+306
| +2% | +$4.09K |
|
1709
Brown-Forman Class A
BF.A
$12.3B
| $198K | ﹤0.01% |
3,877
+3,854
| +16,757% | +$187K |
|
|
EGOV
1710
DELISTED
NIC Inc
EGOV
| $198K | ﹤0.01% |
11,584
-2,552
| -18% | -$40.4K |
|
1711
Home BancShares
HOMB
$6.09B
| $197K | ﹤0.01% |
11,237
+560
| +5% | +$10.4K |
|
|
BFX
1712
DELISTED
BowFlex Inc.
BFX
| $195K | ﹤0.01% |
35,138
+16,526
| +89% | +$128K |
|
1713
LSB Industries
LXU
$852M
| $193K | ﹤0.01% |
40,200
+2,950
| +8% | +$15.7K |
|
|
CAMP
1714
DELISTED
CalAmp Corp.
CAMP
| $193K | ﹤0.01% |
666
+73
| +12% | +$23.1K |
|
|
CPLG
1715
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $193K | ﹤0.01% |
17,285
+3,528
| +26% | +$45.5K |
|
|
RDC
1716
DELISTED
Rowan Companies Plc
RDC
| $193K | ﹤0.01% |
17,854
-5,835
| -25% | -$68K |
|
|
RPAI
1717
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $185K | ﹤0.01% |
15,189
+4,700
| +45% | +$57.3K |
|
|
CMO
1718
DELISTED
Capstead Mortgage Corp.
CMO
| $182K | ﹤0.01% |
21,174
+275
| +1% | +$2.15K |
|
|
BRKL
1719
DELISTED
Brookline Bancorp
BRKL
| $180K | ﹤0.01% |
12,525
+819
| +7% | +$12.3K |
|
|
TTSH
1720
DELISTED
Tile Shop Holdings
TTSH
| $178K | ﹤0.01% |
31,431
-1,539
| -5% | -$10K |
|
1721
Cohu
COHU
$2.6B
| $174K | ﹤0.01% |
11,788
+677
| +6% | +$11.5K |
|
1722
Xenon Pharmaceuticals
XENE
$6.4B
| $173K | ﹤0.01% |
16,998
-8,933
| -34% | -$75.7K |
|
1723
Cousins Properties
CUZ
$5.14B
| $168K | ﹤0.01% |
4,342
-6,215
| -59% | -$227K |
|
|
RPT
1724
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $157K | ﹤0.01% |
+13,106
| New | +$163K |
|
|
FSP
1725
Franklin Street Properties
FSP
$45.9M
| $152K | ﹤0.01% |
21,201
+1,935
| +10% | +$13.9K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.